Sep 26, 2023 / 07:30PM GMT
Louise Alesandra Chen - Cantor Fitzgerald & Co., Research Division - MD & Senior Research Analyst
All right. Good day, everybody. Thank you for joining us for our keynote address with the Chairman and CEO of Pfizer, Dr. Albert Bourla. Dr. Bourla, it's so nice to have you here with us again for our keynote speech at our health care conference.
Questions and Answers:
Louise Alesandra Chen - Cantor Fitzgerald & Co., Research Division - MD & Senior Research AnalystLast time that we were together, it was 2021, and we were in the middle of the COVID pandemic. So obviously, a lot to talk about then. So thank you for all your contributions to bring us back to normalcy.
But as we sit here, again, we're in another inflection point in the fight against COVID. We've got new variants, increasing hospitalization rates, a lot of uncertainty heading into the fall and winter. So Dr. Bourla, how do you look at COVID unfolding over the next few months?
Albert Bourla - Pfizer Inc. - Chairman of the Board & CEO